đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
FIT-AGING will determine the effect of different exercise modalities on α-K...
Status
Completed
Location
Multiple Locations
Start Date
2016-06-01
Trial ID
NCT03334357
This substudy is part of an umbrella platform study which is designed to ev...
Status
Recruiting
Location
University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 1045)
Start Date
2022-11-16
Trial ID
NCT05562830
Treatments Being Tested
This study consists of several parts: dose escalation, dose expansion, dose...
Status
Completed
Location
University of California at San Francisco ( Site 0004)
Start Date
2018-07-11
Trial ID
NCT03564691
Treatments Being Tested
A phase II study combining pembrolizumab with olaparib in metastatic pancre...
Status
Recruiting
Location
Monash Health
Start Date
2025-02-26
Trial ID
NCT05093231
Treatments Being Tested
This study will evaluate the efficacy and safety of pembrolizumab (MK-3475)...
Status
Completed
Location
Comprehensive Blood & Cancer Center [Bakersfield, CA] ( Site 1604)
Start Date
2019-06-26
Trial ID
NCT03976375
Treatments Being Tested
Primary Objectives: Phase 1 -To characterize the safety and tolerability ...
Status
Terminated
Location
Investigational Site Number :2500005
Start Date
2018-12-11
Trial ID
NCT03769181
Treatments Being Tested
This trial is a phase 1/1b study to evaluate the safety, efficacy, and tole...
Status
Completed
Location
Yale Cancer Center
Start Date
2018-06-09
Trial ID
NCT03502330
Treatments Being Tested
The main purpose of this study is to determine the best dose of MEDI6469 th...
Status
Terminated
Location
Research Site
Start Date
2014-08-13
Trial ID
NCT02205333
This is a multi-center, open-label, first-in-human Phase 1 study evaluating...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2016-03-07
Trial ID
NCT02715284
Treatments Being Tested
Participants with recurrent or metastatic (R/M) squamous cell cancer of the...
Status
Completed
Location
Multiple Locations
Start Date
2015-03-19
Trial ID
NCT02358031
Treatments Being Tested